Moreover, tryptophan-derived metabolites produced by the gut microbiota was found to control the expression of the miR-181 family, which promote the development of insulin resistance and WAT inflammation in obese mice and humans, to regulate energy expenditure and insulin sensitivity [243]. The gene discussed is INS; the disease is Insulin resistance.